It’s how the FDA protects big pharma. Just like our future BLA for HIV. Leronlimab can only be used after 2 other drugs have failed. Not because Leronlimab is better… which it is… we can only sell or use or be prescribed Leronlimab if 2 other drugs have failed to keep the 50 ml count down. Why hold Leronlimab back when it is better and safer than the already approved drugs with black box warnings? We don’t need to have a supplementary drug prescribed with Leronlimab either but that is the only way we will be approved util the mono trial is approved and we can go it alone.

The FDA plays god with peoples health not just because they can… because they protect the money going to big Pharma… how wrong is this???